Bluejay Diagnostics announces 1-for-4 reverse stock split effective November 3
BJDX•Bluejay Diagnostics will implement a 1-for-4 reverse stock split effective November 3, 2026. Outstanding common shares will decline from approximately 4,468,051 to approximately 1,117,013.
1. Split details
Bluejay Diagnostics will implement the split at 12:01 a.m. Eastern Time on November 3, 2026. Shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market that day under the existing symbol BJDX. Cash payments will replace fractional shares, and outstanding equity awards and warrants will be adjusted accordingly.
